Effectiveness of a Resilience-Based Rehabilitation Program for Patients with Coronary Heart Disease
Launched by PENSIONSVERSICHERUNGSANSTALT · Mar 20, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special program that focuses on building psychological resilience can help patients who have experienced heart issues, specifically those with Takotsubo cardiomyopathy or recent heart events like a heart attack. Resilience is the ability to cope with stress and challenges in everyday life, which can be especially important for people recovering from heart conditions. The goal of the trial is to see if adding resilience training to the usual rehabilitation program can improve the emotional well-being and recovery of these patients.
To participate in this trial, individuals must be over 18 years old and have experienced either Takotsubo cardiomyopathy or a heart event within the last six months. It's important that they can understand the training in German. Participants will be part of a rehabilitation program where therapists will tailor their care to each person's needs, including this new focus on building resilience. This could help patients handle stress better and improve their overall recovery journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients experienced TakoTsubo cardiomyopathy (I42.88, I42.9) or patients after an acute coronary event (I21.9) (max. 6 month post event)
- • older than 18 years
- • signed consent form
- Exclusion Criteria:
- • Acute intercurrent illness (longer than 3 days)
- • No sufficient knowledge of German to enable participation in the resilience training (assessment by recruiting person)
About Pensionsversicherungsanstalt
Pensionsversicherungsanstalt (PVA) is a prominent Austrian institution dedicated to the administration of pension insurance, ensuring financial security for its beneficiaries through comprehensive pension schemes and services. With a commitment to enhancing the quality of life for retirees, PVA actively engages in clinical trials to explore innovative health solutions and improve healthcare outcomes for its members. By collaborating with research institutions and healthcare providers, PVA aims to contribute valuable insights to the fields of gerontology and chronic disease management, ultimately fostering a healthier aging population.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bad Tatzmannsdorf, Burgenland, Austria
Patients applied
Trial Officials
Doreen Stöhr, Mag.
Study Chair
Austrian Pension Insurance Institution
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported